Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
Clinical trial NCT03042468 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03042468
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2021-09-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.